Adjuvant chemotherapy and differential invasive breast cancer specific survival in elderly women

Journal of Geriatric Oncology

Volumn 4, Issue 2, 2013, Pages 148-156

  Kaplan, Henry G ^a   Malmgren, Judith A ^b,c   Atwood, Mary K ^a  

^a SWEDISH MEDICAL CENTER   (United States)

^b HealthStat Consulting Inc   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Adjuvant chemotherapy; Breast cancer; Breast neoplasm; Disease specific survival; Elderly; Risk modeling; Survival analysis

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PACLITAXEL; PROGESTERONE RECEPTOR; TAXANE DERIVATIVE; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; COHORT ANALYSIS; DISEASE SPECIFIC SURVIVAL; DRUG ERUPTION; DRUG FATALITY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPONATREMIA; LOW DRUG DOSE; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MULTIPLE CYCLE TREATMENT; NEUROPATHY; NEUROTOXICITY; NEUTROPENIA; PATIENT DECISION MAKING; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT REFUSAL;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MASTECTOMY; RADIOTHERAPY, ADJUVANT; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; TREATMENT REFUSAL;

EID: 84875618039     PISSN: 18794068     EISSN: 18794076     Source Type: Journal    
DOI: 10.1016/j.jgo.2012.12.007     Document Type: Article

References (28)

1. National Center for Health Statistics Health, United States, 2010: with special feature on death and dying 2011, Hyattsville, MD. http--www.cdc.gov-nchs-data-hus-hus10.pdf.
2. http://www.seer.cancer/statfacts/html/breast.html.
3. NCCN practice guidelines in oncology - version 2.2010, 3/16/2010 © 2010, National Comprehensive Cancer Network, Inc., BINV-5,6.
4. Wildiers H., Kunkler I., Biganzoli L., Fracheboud J., Vlastos G., Bernard-Marty C., et al. Management of breast cancer in elderly individuals>recommendations of the International Society of Geriatric Oncology. Lancet Oncol 2007, 8(12):1101-1115.
5. Smith B.D., Jiang J., McLaughlin S.S., Hurria A., Smith G.L., Giordano S.H., et al. Improvement in breast cancer outcomes over time: are older women missing out?. J Clin Oncol 2011, 29:4647-4653.
6. AJCC cancer staging 2002, Springer-Verlag, New York. 6th ed.
7. Cancer Surveillance System of the Fred Hutchinson Cancer Research Center, contract no. N01-CN-67009, Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute, Bethesda, MD.
8. IBM SPSS Statistics 18.0.0, formerly PASW Statistics 18.0.0 2009, SPSS Inc., Chicago, Ill.
9. Barcenas C.H., Zhang N., Zhao H., Duan Z., Buchholz T.A., Hortobagyi G.N., et al. Anthracycline regimen adherence in older patients with early breast cancer. Oncologist 2012, 17:303-311.
10. Ibrahim N.K., Buzdar A.U., Asmar L., Therialut R.L., Hortobagyi G.N. Doxorubicin-based adjuvant chemotherapy in elderly breast cancer patients: the M.D. Anderson experience, with long term follow-up. Ann Oncol 2000, 11:1597-1601.
11. Nuzzo F., Morabito A., De Maio E., Di Rella F., Gravina A., Labonia V., et al. Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the mulitcentre phase 3 randomised ELDA trial. Crit Rev Oncol Hematol 2008, 66:171-180.
12. Ring A., Sestak I., Baum M., Howell A., Buzdar A., Dowsett M., et al. Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the arimidex, tamoxifen alone or in combination trial. J Clin Oncol 2011, 29(32):4266-4272.
13. Van de Water W., Markopoulos C., van de Velde C.J.H., Seynaeve C., Hasenburg A., Rea D., et al. Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. J Am Med Assoc 2012, 307(6):590-597.
14. Giordano S.H., Hortobagyi G.N., Kau S-W C., Theriault R.L., Bondy M. Breast cancer treatment guidelines in older women. J Clin Oncol 2005, 23(4):783-791.
15. Enger S.M., Thwinn S.S., Buist D.S.M., Field T., Frost F., Geiger A.M., et al. Breast cancer treatment of older women in integrated health care settings. J Clin Oncol 2006, 24(27):4377-4383.
16. Bouchardy C., Rapiti E., Blagojovic S., Vlastos A.-T., Vlastos G. Older female cancer patients: importance, causes, and consequences of undertreatment. J Clin Oncol 2007, 25(14):1858-1869.
17. Bastiaannet E., Liefers G.J., de Craen A.J.M., Kuppen P.J.K., van de Water W., Portielje J.E.A., et al. Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients. Breast Cancer Res Treat 2010, 10.1007/s10549-010-0898-8.
18. Weggelaar I., Aben K.K., Warle M.C., Strobbe L.J., van Spronsen D.J. Declined guideline adherence in older breast cancer patients: a population-based study in The Netherlands. Breast J 2011, 10.1111/j.1524-4741.2011.01074.x.
19. Wheeler S.B., Carpenter W.R., Peppercorn J., Schenk A.P., Weinberger M., Biddle A.K. Predictors of timing of adjuvant chemotherapy in older women with hormone receptor-negative, stages II-III breast cancer. Breast Cancer Res Treat 2012, 131:207-216. 10.1007/s10549-011-1717-6.
20. Albert J.M., Pan I.-W., Shih Y-C T., Jiang J., Buchholz T.A., Giordano S.H., et al. Effectiveness of radiation for prevention of mastectomy in older breast cancer patients treated with conservative surgery. Cancer 2012, 118:4642-4651. 10.1002/cncr27457.
21. Hughes K.S., Schnaper L.A., Berry D., Cirrincione C., McCormick B., Shank B., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70years or older with early breast cancer. N Engl J Med 2004, 351(10):971-977.
22. Hughes K.S., Schnaper L.A., Cirrincione C., Berry D.A., McCormick B., Muss H.B., et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 and older with early breast cancer. J Clin Oncol 2010, 28:15s. [Suppl.;abstr 507].
23. Oladipo O., Coyle V., McAleer J.J., McKenna S. Achieving optimal dose intensity with adjuvant chemotherapy in elderly breast cancer patients: a 10-year retrospective study in a UK institution. Breast J 2012, 18(1):16-22. 10.1111/j.1524-4741.2011.01177.x.
24. Muss H.B., Berry D.A., Cirrincione C.T., Theodoulou M., Mauer A.M., Kornblith A.B., et al. Adjuvant chemotherapy of older women with early-stage breast cancer. N Engl J Med 2009, 360(20):2055-2065.
25. Kornbluth A.B., Lan L., Archer L., Partridge A., Kimmick G., Hudis C., et al. Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907. J Clin Oncol 2011, 29(8):1022-1028.
26. Laki F., Kirova Y.M., Savignoni A., Campana F., Levu B., Esteve M., et al. Management of operable invasive breast cancer in women over the age of 70: long-term results of a large-scale single-institution experience. Ann Surg Oncol 2010, 17:1530-1538. 10.1245/s10434-010-0967-6.
27. Giordano S.H., Duan Z., Kuo Y.-F., Hortobagyi G.N., Goodwin J.S. Use and outcomes of adjuvant chemotherapy in older women with breast cancer. J Clin Oncol 2008, 24(18):2750-2756.
28. Muss H.B., Woolf S., Berry D., Cirrincione C., Weiss R.B., Budman D., et al. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. J Am Med Assoc 2005, 293(9):1073-1081.